Femasys Launches Pivotal Trial for FemBloc Birth Control
Atlanta, United States – March 10, 2026 Femasys Inc. has announced the initiation of patient enrollment in the FINALE...
Healthcare Innovation
Advertisement
Menarini Nears €4.9B Revenue, Expands AI Drug Discovery
Florence, Italy – March 9, 2026 Menarini Group, one of Europe’s leading pharmaceutical companies, has reported strong financial growth...
Myriad Genetics Advances Precision Medicine at Q4 2025 Forums
Dateline — SALT LAKE CITY, November 11, 2025:Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostic testing...
Kedrion Biopharma Launches YIMMUGO® for PI in the U.S.
FORT LEE, N.J., October 9, 2025 — Kedrion Biopharma today announced the U.S. commercial launch of YIMMUGO® (Immune Globulin...
Sanofi Expands Sanofi Ventures With $625M to Drive Biotech Innovation
PARIS, Sept. 24, 2025 — Sanofi announced a $625 million capital expansion for its corporate venture fund, Sanofi Ventures,...
Advertisements
Elutia Sells BioEnvelope Business to Boston Scientific for $88 Million
MALVERN, Pennsylvania, September 10, 2025 — Elutia has announced the sale of its BioEnvelope business to Boston Scientific Corporation...
FDA Approves J&J’s INLEXZO™, Redefining Bladder Cancer Care
September 9, 2025 – Raritan, N.J. – In a landmark regulatory milestone, Johnson & Johnson (NYSE: JNJ) announced U.S....
BridgeBio Secures $300 Million Upfront Through Royalty Monetization of BEYONTTRA in Europe
PALO ALTO, CA., June 30, 2025 — BridgeBio Pharma, Inc. (Nasdaq: BBIO), the biopharmaceutical company dedicated to developing transformative...
Bio-Thera and STADA Expand Alliance with Biosimilars-Tocilizumab
August 22, 2025 — Bio-Thera Solutions and STADA Arzneimittel have announced the expansion of their biosimilars partnership to include...
FDA Recalls Frozen Shrimp Because of Possible Health Risk
August 21, 2025: The U.S. Food and Drug Administration (FDA) has issued a public health advisory cautioning against consumption,...
Advertisement
